Cat Inflammatory Bowel Disease: Diagnosis, Management, and Welfare

Inflammatory bowel disease (IBD) is a common chronic gastrointestinal condition in cats causing vomiting, diarrhoea, and weight loss that significantly impairs quality of life but can be managed effectively with appropriate diagnosis and treatment.

Key Facts

Feline IBD encompasses a group of chronic intestinal inflammatory disorders classified by predominant cell type.
Symptoms include chronic vomiting, diarrhoea, weight loss, and reduced appetite over weeks to months.
Diagnosis requires intestinal biopsy — either surgical or endoscopic — to definitively characterise the disease.
Dietary modification using novel protein or hydrolysed protein diets is often the first-line management approach.
Prednisolone is the most commonly used immunosuppressive drug, with chlorambucil added for refractory cases.
Feline IBD must be distinguished from intestinal lymphoma, which can present identically and requires different treatment.
Cobalamin (B12) deficiency is common in cats with IBD and supplementation improves clinical outcomes.

Welfare Considerations

Chronic IBD causes significant welfare impairment — persistent vomiting is distressing, weight loss indicates nutritional failure, and the associated nausea and abdominal discomfort reduce quality of life substantially. Many cats with IBD also develop secondary food aversions from repeatedly feeling ill after eating. Management requires commitment to monitoring and adjustment — dietary trials take 6-8 weeks to assess, and medication doses require regular review. Vitamin B12 supplementation is often overlooked but can dramatically improve appetite and energy. The goal of management is to achieve clinical remission with minimal medication side effects.

What You Can Do

Pursue definitive diagnosis including biopsies rather than treating empirically without characterising the disease type.
Discuss dietary trial protocols with your vet — true dietary IBD requires strict elimination of previous protein sources.
Monitor B12 levels and supplement if deficient — it is inexpensive and often significantly improves clinical signs.
Use validated quality of life scoring to objectively assess whether current treatment is achieving adequate welfare.